Pediatric acute graft‐versus‐host disease prophylaxis and treatment: surveyed real‐life approach reveals dissimilarities compared to published recommendations
Ánita Lawitschka(St Anna Children's Hospital), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Peter Bader(Goethe University Frankfurt), Arnaud Dalissier(Inserm), Brigitte Strahm(University Medical Center Freiburg), Isaac Yaniv(Tel Aviv University), Dorothea Bauer(St Anna Children's Hospital), Roland Meisel(Düsseldorf University Hospital), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Jacek Wachowiak(Poznan University of Medical Sciences), Selim Corbacioglu(Unknown), Adriana Balduzzi(Azienda Ospedaliera San Gerardo), Victoria Bordon(Ghent University Hospital), Kim Vettenranta(Universität Hamburg), Giovanna Lucchini(Great Ormond Street Hospital), Jean‐Hugues Dalle(Inserm), Brenda Gibson(Royal Hospital for Children)
Cited by 33
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
|Blood|2004|1.6k
Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0
|Nature Protocols|2019|1.4k